315 related articles for article (PubMed ID: 36330423)
1. Neuroimaging features in inflammatory myelopathies: A review.
Cacciaguerra L; Sechi E; Rocca MA; Filippi M; Pittock SJ; Flanagan EP
Front Neurol; 2022; 13():993645. PubMed ID: 36330423
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD.
Fadda G; Flanagan EP; Cacciaguerra L; Jitprapaikulsan J; Solla P; Zara P; Sechi E
Front Neurol; 2022; 13():1011579. PubMed ID: 36419536
[TBL] [Abstract][Full Text] [Related]
4. Identifying specific myelopathy etiologies in the evaluation of suspected myelitis: A retrospective analysis.
Alkabie S; Casserly CS; Morrow SA; Racosta JM
J Neurol Sci; 2023 Jul; 450():120677. PubMed ID: 37207546
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune myelopathies.
Flanagan EP
Handb Clin Neurol; 2016; 133():327-51. PubMed ID: 27112686
[TBL] [Abstract][Full Text] [Related]
6. Immune-Mediated Disorders Affecting the Spinal Cord and the Spine.
Perez Giraldo GS; Ortiz Garcia JG
Curr Neurol Neurosci Rep; 2021 Jan; 21(1):3. PubMed ID: 33392785
[TBL] [Abstract][Full Text] [Related]
7. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
[TBL] [Abstract][Full Text] [Related]
8. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.
Sechi E; Cacciaguerra L; Chen JJ; Mariotto S; Fadda G; Dinoto A; Lopez-Chiriboga AS; Pittock SJ; Flanagan EP
Front Neurol; 2022; 13():885218. PubMed ID: 35785363
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in immune-mediated myelopathies.
Wendebourg MJ; Nagy S; Derfuss T; Parmar K; Schlaeger R
J Neurol; 2020 May; 267(5):1233-1244. PubMed ID: 30694379
[TBL] [Abstract][Full Text] [Related]
10. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
Front Immunol; 2022; 13():897959. PubMed ID: 35774780
[TBL] [Abstract][Full Text] [Related]
11. MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders.
Shahriari M; Sotirchos ES; Newsome SD; Yousem DM
AJR Am J Roentgenol; 2021 Apr; 216(4):1031-1039. PubMed ID: 32755221
[TBL] [Abstract][Full Text] [Related]
12. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune and Paraneoplastic Myelopathies.
Zalewski NL; Flanagan EP
Semin Neurol; 2018 Jun; 38(3):278-289. PubMed ID: 30011409
[TBL] [Abstract][Full Text] [Related]
14. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
Zalewski NL; Morris PP; Weinshenker BG; Lucchinetti CF; Guo Y; Pittock SJ; Krecke KN; Kaufmann TJ; Wingerchuk DM; Kumar N; Flanagan EP
J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):218-225. PubMed ID: 27913626
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging of Spinal Cord and Cauda Equina Disorders.
Diehn FE; Krecke KN
Continuum (Minneap Minn); 2021 Feb; 27(1):225-263. PubMed ID: 33522744
[TBL] [Abstract][Full Text] [Related]
16. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
[TBL] [Abstract][Full Text] [Related]
17. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
19. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
20. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
